Quantcast

Latest Genmab Stories

2008-10-10 12:00:42

COPENHAGEN, Denmark, October 10 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today it has reached the sixth milestone for ofatumumab (HuMax-CD20(R)) under the terms of its collaboration with GlaxoSmithKline (GSK).

2008-10-06 12:00:43

Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue.

2008-09-23 12:00:51

COPENHAGEN, September 23 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today it has completed recruitment of patients in the pivotal Phase III study of ofatumumab (HuMax-CD20(R)) in rituximab refractory follicular non-Hodgkin's lymphoma (NHL).

2008-09-23 09:01:09

Genmab, an international biotechnology company, has completed recruitment of 56 previously untreated follicular non-Hodgkin's lymphoma patients in the Phase II study of ofatumumab in combination with cyclophosphamide, doxorubicin, vincristine and prednisone.

2008-09-22 09:00:58

COPENHAGEN, September 22 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today it has completed recruitment of 56 previously untreated follicular non-Hodgkin's lymphoma (NHL) patients in the Phase II study of ofatumumab (HuMax-CD20(R)) in combination with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP).

1f5f20ccf84ea9e4eb75ca859981bbb21
2008-09-12 12:44:49

The head of biotech research GlaxoSmithKline Plc said a new generation of "slimline" antibody medicines may be successors to current blockbusters such as Avastin and Rituxan.

2008-08-26 09:01:20

Genmab has announced plans to begin four studies of ofatumumab in chronic lymphocytic leukemia and follicular non-Hodgkin's lymphoma in 2008.

2008-08-25 03:00:16

COPENHAGEN, Denmark, August 25 /PRNewswire-FirstCall/ -- Genmab has announced plans to begin four studies of ofatumumab in chronic lymphocytic leukemia and non-Hodgkin's lymphoma.

2008-08-21 12:01:28

COPENHAGEN, August 21 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today it has reached the fifth milestone for ofatumumab (HuMax-CD20(R)) under the terms of its collaboration with GlaxoSmithKline (GSK).

2008-08-20 09:01:30

SCOTTSDALE, Ariz., Aug. 20 /PRNewswire/ -- MedPredict, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for pharma and biotech companies with a stake in the market for multiple sclerosis (MS) therapies.


Word of the Day
inwit
  • Inward knowledge; understanding; conscience.
The word 'inwit' comes from Middle English inwit ("mind, reason, intellect, understanding; soul, spirit; feeling; the collection of inner faculties; one of five inner faculties; one of the outer bodily senses.; inward awareness of right or wrong, conscience"), from Old English *inwitt, inġewitnes ("consciousness, conscience, knowledge, knowing"), equivalent to in- +‎ wit. (Wiktionary)
Related